A new report commissioned by the National Pharmacy Association (NPA) has revealed harsh financial realities faced by community pharmacies in England.
The report by Professor David Taylor of University College London warned that 1000s of community pharmacy closure might take place by 2024 in England if the sector
was not supported with additional funds.
At the launch of the report titled 'Protecting UK Public Interests in NHS Community Pharmacy', Prof Taylor said: "There will be several 1,000s of closures over the
next few years unless we take appropriate action, which doesn't mean to pour money all over it, but it is to fund appropriately when necessary.
"At the moment, if we got a partial collapse in the pharmacy network it would disrupt medicine supply and increase health inequalities… For me, it's missing out on
the future development of better and more accessible care, which would be the tragedy of reducing, harming and damaging the pharmacy network unnecessarily."
The Pharmacists' Defence Association (PDA) has reacted to the chief pharmaceutical officer (CPhO) for Wales's offer for community pharmacy contractors,
offering a funding uplift for community pharmacy on the condition of an increase in pay for some staff by at least the amount currently being imposed upon NHS
employees.
The PDA has expressed a mixed reaction to the intervention being attempted by the Welsh government.
"It is unusual for a government to be so closely involved in the pay of their suppliers' employees and those at some community pharmacy employers have a contractual
right to a pay review at times of year that may not synchronize with the government's financial cycle, so this initiative may have different impacts at different
employers," said the association.
"In addition, the PDA negotiates pay at the largest two community pharmacy employers and works alongside other trade unions that organise other pharmacy workers.
This government intervention must not disrupt or attempt to bypass those processes."
Community Pharmacy England (CPE) has explained MPs on instability that puts operational pressures on pharmacies, financial pressures on businesses at a
Parliamentary drop-in event held on Monday (10 July).
The association has been in Parliament today alongside patient representatives and others to highlight our ongoing concerns about medicines supply to MPs.
It said: "Medicines supply remains a critical issue for community pharmacies with disruption causing problems both accessing medicines and procuring them cost
effectively."
In CPE's recent sector polling, community pharmacy owners rated medicines supply instability as being the most severe pressure facing their businesses. This
echoed the results of CPE's Pressures Survey which found 97% of pharmacy owners survey are facing significant increases in wholesaler and medicine supply issues,
with 71% saying this was leading to delays in prescriptions being issued.
During the Parliamentary drop-in event, CPE talked MPs through the issues and set out what it believe needs to happen to resolve them, calling for- Reform of
Serious Shortage Protocols; Allowing generic substitution; An overhaul of the concessions system; and a strategic Government review of medicine supply and pricing
with a shift to focusing on how to improve the functioning of the supply chain rather than solely on the drive to depress prices and margins.
Two pharmacies in Rotherham are set to merge into one, if plans are approved by NHS England.
Weldricks Pharmacy has applied to merge its two Swinton branches, on Church Street and the Crown Street Surgery.
If approved, the branch on Church Street will be modernised, and additional consulting rooms will be added, while the Crown Street site will be closed.
Rotherham Met Borough Council's health and wellbeing board are set to make a representation supporting the plans, and say that analysis by public health "outlines
the very minimal impact that this change will have in terms of pharmacy access in the borough based on the service offer, opening hours and walking times to this
branch and the main pharmacy."
They say the current opening hours will remain the same, and there will be no disruption to services during the consolidation.
A statement from Weldricks adds that the decision to merge is down to funding cuts, and the company could go out of business if operating costs are not reduced -
'despite having been a local, family-owned business for almost 100 years'.
A massive global technology outage on Friday has disrupted essential services, including healthcare, airlines, banks, and broadcasters worldwide.
The outage, attributed to a flawed update from cybersecurity firm CrowdStrike, has also affected the National Health Service (NHS) in the UK, with several hospitals
and GP practices losing access to their computer systems.
Community pharmacies are also facing significant disruptions. Services such as accessing prescriptions from GPs and medicine deliveries have been affected, causing
inconvenience to patients and healthcare providers.
An NHS spokesperson said: "The NHS is aware of a global IT outage and an issue with EMIS, an appointment and patient record system, which is causing disruption in
the majority of GP practices."
The spokesperson assured that the NHS has long-standing measures in place to manage such disruptions, including the use of paper patient records and handwritten
prescriptions, and the usual phone systems to contact GPs.
Amid media speculations that a large pharmacy multiple was putting all its stores at risk of closure, PSNC supremo Janet Morrison said the sector was in
crisis and in danger of a significant collapse.
Addressing delegates via a video link at Sigma Pharmaceutical's 13th Annual Community Pharmacy Conference held last week (March 4 -9) in Punta Cana, Dominican
Republic, she said while "a lot of consolidation or sales" would continue, a lot of the smaller, independently-owned community pharmacies - which had to work harder
and harder to make ends meet - were just "hanging on in there".
"But I don't know how much longer people can go on," she said, adding that the risk of actual closure was rendering the remaining pharmacies so fragile that "they
may not be able to pick up the slack of many thousands of patients" who would need repeat prescriptions.
"The disruption is frightful and awful. We have got 53 per cent of the population on repeat prescriptions, so that matters."
Her comment on the opening day of the conference was a sober reminder that the sector - which relies heavily on income from prescriptions - couldn't afford to
"carry on with the current format of a contract and the current amount of money" it was paid to deliver numerous tasks which have been heaped on it to share the
burden of a crippling NHS.
In a recent meeting with the head of the government's HRT Taskforce, Madelaine McTernan, the National Pharmacy Association (NPA) board members gave a gist on the ongoing medicines supply issues in community pharmacy.
The meeting, which explored possible solutions to end the nationwide shortage of some Hormone Replacement Therapies, took place on Friday (May 20).
Independent contractors Reena Barai and Olivier Picard gave the so-called 'HRT tsar' an overview of the medicines supply issues in community pharmacy and discussed the new Serious Shortage Protocols (SSPs) which the government introduced in response to the on-going HRT disruption.
Earlier this month, the NPA attended an HRT summit organised by the Department of Health and Social Care, alongside other pharmacy bodies, wholesalers and manufacturers.
Health secretary Sajid Javid and pharmacy minister Maria Caulfield said they would be working collaboratively with manufacturers to meet demand and boost supply.
Community Pharmacies are set to significantly upgrade their digital security as the mandatory rollout of NHSmail Multi-Factor Authentication (MFA) begins
this month (August 1, 2024).
In an announcement by the Community Pharmacy England (CPE), pharmacies are urged to make the updates following a period of optional MFA implementations that began
in late 2023.
According to the new requirements, the mandatory update is crucial for protecting patient privacy and the integrity of their health records.
By adding an extra layer of security beyond the standard email address and password, MFA helps safeguard against unauthorised access.
This is especially vital in light of increasing cyber threats targeting healthcare systems.
Cyberattacks, including ransomware, can compromise patient records and disrupt care delivery, making robust security measures essential.
The introduction of MFA aims to curb these risks.
According to cybersecurity research, MFA can prevent up to 80 per cent data breaches and block over 99.9 per cent of compromised accounts.
Speaking at the SIGMA Conference 2023, Dr Leyla Hannbeck, CEO of the Association of Independent Multiple Pharmacies (AIMp), spoke about the increasing
number of prescriptions, lack of funding and other existing challenges.
Leyla explained how the pharmacy sector is facing immense challenges which are disrupting the delivery of services as well as impacting its growth.
She further spoke about the hub and spoke model, and how it is unable to solve the issues.
"Community pharmacies are clogged with prescription volume, and this is preventing them from supporting the wider NHS as well as offering services," she said.
She said that the prescription volumes have rocketed, while the number of pharmacies in England has declined from 11, 522 in the year 2021-22 to 11, 414 in 2022-23.
When it comes to Company Chemists' Association (CCA) pharmacies, there has been a loss of 1055 branches from 2022 to 2023.
The PSNC on Friday said it has warned the DHSC about the "very serious impact" of the limited supply of certain antibiotics on pharmacies who are "having to
chase stock, purchase without sight of any concession prices, and cope with increasing patient questions and abuse."
With higher than usual number of cases of scarlet fever, caused by invasive Group A Streptococci (iGAS) infections, being reported in children across the country,
supplies of antibiotics for Group A Strep treatment have seen a surge in demand, leading to limited supply at certain wholesalers and pharmacies.
PSNC has urged the DHSC to adopt measures that could help to manage the current crisis, such as allowing pharmacists more freedom to change strengths or formulations
without prescriber approval, outside of Serious Shortage Protocols.
It has also raised concerns on the significant rise in wholesale prices of many oral antibiotics as a result of the surge in demand and the ongoing supply
disruptions. PSNC also said they have received reports of some suppliers putting up their prices for any oral antibiotics they do have in stock.
The National Pharmacy Association (NPA) has announced the retirement of its Chief Executive, Mark Lyonette.
Mark will retire in 2024. The association has announced his retirement well in advance so that the Board can start work with a leading recruitment agency to search
for the new Chief Executive.
"The Board is keen to build on the strong foundations established and ensure there is a seamless transition and minimum disruption to the business once the new Chief
Executive is in post," said the association.
Mark said: "After five years at the NPA and 40 years working for and leading national membership organisations, I am looking forward to living a different life.
"I am pleased that in the time that I have been with the NPA we have grown both the membership and customer base and created a profitable, stable membership
organisation.
"Alongside our NPA Insurance company, the association is well set to help members face the future.
"Meanwhile there is much to do to ensure that 2023 is another good year in terms of the NPA delivering consistently for members. The process of changing Chief
Executive won't deflect us from our vital work."
The Pharmacists' Defence Association has reported an increase in the number of pharmacists calling its advice line to inform about the incidences of violence and intimidation from protesters opposing the Covid-19 vaccination programme.
The association noted that such incidents have become more common with protesters "gaining entry to premises in groups and trying to disrupt Covid-19 vaccinations from taking place."
In many cases, pharmacists, staff, and members of the public have been subjected to verbal threats, causing distress and anxiety among those working to deliver the vaccination programme in a safe environment.
The PDA reminded that employers, having a contract with the NHS for the Covid-19 vaccinations, have a duty to keep their staff safe whilst at work.
The General Pharmaceutical Council (GPhC) standards for pharmacy premises also carry a duty to ensure the safety of staff and the public receiving services on those premises.
The European Parliament on Thursday adopted a proposal from Brussels to ensure the continued supply of medicines from Britain to Northern Ireland - an issue that had dogged the bloc since London left it.
"Great news from the @Europarl_EN today with the overwhelmingly positive vote to ensure the continued supply of medicines to Northern Ireland," tweeted Maros Sefcovic, European Commission vice president who had been leading discussions with London.
"The EU is delivering on this lasting solution for Northern Ireland in record time," he added, though the EU Council must give final approval.
Britain itself has yet to give formal approval on a move that would avoid potential disruption of supplies as London wants an overall accord for matters pertaining to the Northern Ireland protocol governing post-Brexit trade.
The Department of Health and Social Care (DHSC) has issued a further five new Serious Shortage Protocols (SSPs) for Phenoxymethylpenicillin (Pen V) to enable
the continued supply of antibiotics to patients.
"The new SSPs, introduced with immediate effect, allow community pharmacists to consider different oral antibiotic preparations, to enable the continued supply of
antibiotics to patients and mitigate the ongoing supply disruptions affecting Phenoxymethylpenicillin," said DHSC.
On Friday (16 December) SSP043-SSP047 has been authorised by the Secretary of State to provide pharmacists with procedures to follow in providing suitable alternative
oral antibiotics to substitute Phenoxymethylpenicillin.
"For each SSP, DHSC has included specific patient counselling points which must be taken into account when deciding whether supply in accordance with an SSP is
suitable for a patient."
In response to significant ongoing disruptions in the supply of certain Quetiapine tablet strengths, the Department of Health and Social Care (DHSC) on Tuesday
issued nine new Serious Shortage Protocols (SSPs), with immediate effect.
These measures aim to ensure the continued availability of quetiapine, an essential medication for managing schizophrenia and bipolar disorder.
Under the new SSPs, community pharmacists are allowed to consider different options to manage the shortage of the three strengths of quetiapine tablets affected
by ongoing supply disruptions: quetiapine 300mg tablets, quetiapine 200mg tablets, and quetiapine 150mg tablets.
Depending on the prescribed quantity of the affected quetiapine tablet, pharmacists can either supply a reduced quantity of the same quetiapine tablet or
substitute with an alternative strength or provide a reduced quantity of a specific alternative product.
The Pharmacists' Defence Association (PDA) has reiterated its call for all pharmacists working at Boots to join the PDA Union to support the collective voice of the profession within the company.
It said this would enable PDA to send direct communications to pharmacists working at Boots and keep them up to date with key matters impacting their work life.
Currently, the association uses the company communication channels to cascade key information to the non-member pharmacists, however, it fears such measures can be
disrupted by management.
Besides, having more member pharmacists at Boots would strengthen their "negotiating power", PDA said.
The menopause is a natural aging process, whereby a woman's oestrogen level drops thus disrupting periods until they eventually stop.
A woman is said to be in the menopause when her periods have stopped for 12 months. The age when this usually occurs is between 45-55 but symptoms can begin prior
to this. Symptoms vary and not all women experience them all.
They include hot flushes, vaginal dryness, joint and muscle pain, insomnia, reduced libido, urinary problems such as bladder weakness or Urinary Tract Infections
(UTIs), but this list is not exhaustive.
Up to a third of women declare that the menopause affects their quality of life. It is obvious that such physical changes can have an effect on ones well-being.
Women going through the menopause are at increased risk of developing depression, low self-esteem and problems with concentration (often called brain fog).
There are lots of misconceptions in the public and workplace around menopause as it is a little discussed topic. Did you know 45 per cent of women feel their
menopause symptoms have had a negative impact on their work and 47 per cent of women have said that they won't tell their employer if they need to take a day-off
from work because of menopausal symptoms?
So, with women making up nearly half of the UKs workforce, have you thought about what support your workplace offers for you? And if you are an employer, what could
you be doing to support your colleagues who need help during this time?